ACURATE neo™

Aortic Valve System

Design

Clinical Evidence

Portfolio

Advanced Education

Valve Design

Self-expanding & Supra-annular

Valve Measurements & Sizing

Unique Phased Top-down Deployment

ACURATE neo’s predictable, top-down deployment delivers the hemodynamic stability and precise placement needed for high procedural success and low rates of complications.

Physician experience

"The advantage of the ACURATE neo [valve] is the very quick and intuitive implantation process, and it’s also the convincing clinical data."

Prof. Dr. Tanja Rudolph
Köln, Germany

Delivery Systems

**ACURATE neo Transfemoral Delivery System**

Flexible and intuitive valve delivery and positioning designed to minimize complications and improve procedural efficiency^1,2

Product Specification

Access Route	Transfemoral
Deployment Procedure	Phased, Top-Down Deployment
Guidewire Compatibility	0.035" (0.89 mm)
Usable Length	109 cm
Valve Compatibility	For use with all ACURATE neo Aortic Bioprosthesis (S, M, L)
Introducer Compatibility	14F (≥ 5.5 mm) with iSLEEVE Expandable Introducer Set
Use	Single Use
Sterilization	Gamma Irradiation Process
Carton Size (Delivery System Only)	1,720 mm × 390 mm × 89 mm
Indications for Use	The ACURATE TF Transfemoral Delivery System with the ACURATE neo Aortic Bioprosthesis are indicated to improve valve function for symptomatic patients with severe calcific aortic stenosis (mean aortic gradient > 40 mmHg or peak jet velocity > 4.0 m/s or aortic valve area < 1.0 cm²) with high risk for conventional surgical aortic valve replacement (sAVR). See instructions for use (IFU) for details.

**ACURATE neo Transapical Delivery System**

The only self-expanding, supra-annular valve for transapical TAVI. Low-profile access with straightforward valve delivery and positioning minimizes complications and improves procedural efficiency³

Product Specification

Access Route	Transapical
Deployment Procedure	Phased, Top-Down Deployment
Guidewire Compatibility	0.035" (0.89 mm)
Usable Length	32 cm
Valve Compatibility	For use with all ACURATE neo Bioprosthesis (S, M, L)
Access	Sheathless
Shaft Outer Diameter	19F
Valve Housing Outer Diameter	22F
Use	Single Use
Sterilization	Gamma Irradiation Process
Carton Size (Delivery System Only)	1,130 mm × 390 mm × 89 mm
Indications for Use	The ACURATE neo TA Transapical Delivery System with the ACURATE neo Aortic Bioprosthesis are indicated to improve valve function for symptomatic patients with severe calcific aorticstenosis (mean aortic gradient > 40 mmHg or peak jet velocity > 4.0 m/s or aortic valve area < 1.0 cm²) with high risk for conventional surgical aortic valve replacement (sAVR). See instructions for use (IFU) for details.

See a clinical case

Clinical case

A clinical case performed using the ACURATE neo Aortic Valve and Transapical Delivery System.

Prof. Dr. David Holzhey
Herzzentrum Leipzig, Germany

Results from case studies are not predictive of results in other cases. Results in other cases may vary. Information provided for educational purposes only.

Top